Kathleen P. Bloch - 07 Jul 2023 Form 4 Insider Report for Cytosorbents Corp (CTSO)

Role: Interim CFO
Signature: /s/ Kathleen P. Bloch
Issuer symbol: CTSO
Transactions as of: 07 Jul 2023
Net transactions value: $0
Form type: 4
Filing time: 11 Jul 2023, 20:31:45 UTC
Previous filing: 30 May 2023
Next filing: 20 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CTSO	Common Stock						47,000	07 Jul 2023	See footnote	F1
holding	CTSO	Common Stock						397,347	07 Jul 2023	Direct	F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CTSO	Stock Option (Right to Buy)	Award	$0	+20,000		$0.000000	20,000	07 Jul 2023	Common Stock	20,000	$3.53	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are held by the Reporting Person's husband in a 401(k) account. The Reporting Person may be deemed the beneficial owner of such shares.
F2	Includes: (i) the following RSUs that will be settled into Common Stock upon a "Change In Control" of CytoSorbents Corporation (the "Company"), as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 8,800 RSUs granted on March 15, 2018, (b) 15,700 RSUs granted on February 24, 2017, (c) 47,000 RSUs granted on June 7, 2016 and (d) 110,000 RSUs granted on April 8, 2015;
F3	(continued from footnote 2) (ii) the following RSUs (which vest as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the Reporting Person's continued service as of the applicable vesting date), and will be settled into common stock of the Company upon vesting: 37,000 RSUs granted on August 10, 2022; and
F4	(continued from footnote 3) (iii) 178,847 shares of Common Stock owned by the Reporting Person.
F5	These stock options were granted pursuant to the Plan. The shares underlying these stock options vest fully on the first anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date.